Autres langues NeuroPace, Inc.

Actions

Temps réel estimé Cboe BZX Autres places de cotation 19:55:35 16/07/2024			Varia. 5j.	Varia. 1 janv.
8,165 ^USD	+6,04 %		+20,83 %	-22,07 %

13/05	NEUROPACE, INC. : Morgan Stanley est neutre sur le titre	ZM
08/05	NeuroPace, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell Small Cap Completeness Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell 2000 Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell 3000E Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell 2500 Growth Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell 3000E Growth Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell 3000 Growth Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell 2000 Growth Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell 2000 Dynamic Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell Small Cap Comp Growth Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell 2500 Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell 3000 Index	01/07
NeuroPace to Participate in Two Healthcare Conferences in May	14/05
NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Earnings Flash (NPCE) NEUROPACE Posts Q1 Revenue $18.1M, vs. Street Est of $17.3M	08/05
NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update	08/05
NeuroPace, Inc. Reaffirms Earnings Guidance for the Year 2024	08/05
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024	17/04
NeuroPace to Present at the Needham 23rd Annual Healthcare Conference	27/03
North American Morning Briefing : Inflation -2-	15/03
NeuroPace Shares Decline Following Q4 Financial Results	06/03

Aucun résultat pour cette recherche